M.D.
Urologic Surgeon, Head, Reconstructive Urology
1998, M.D., University of Southern California Medical Center, Los Angeles, CA
2004, Residency in Urology, Los Angeles County + University of Southern California Medical Center, Los Angeles, CA
Kevin Chan, M.D., is a urologic surgeon and the head of reconstructive urology within the Division of Urology and Urologic Oncology at City of Hope® Cancer Center Duarte. Dr. Chan’s clinical expertise includes reconstructive procedures of the urinary tract related to treating a wide range of cancers, including bladder cancer, prostate cancer and upper tract urothelial carcinoma. He also helps patients manage side effects of certain cancer therapies that related to issues such as urinary incontinence and erectile dysfunction, and provides comprehensive care in general urology for conditions including kidney stones and benign prostatic hyperplasia. Dr. Chan leads one of the most extensive programs in the United States that is focused on continent urinary diversion and uses robotic-assisted laparoscopic radical cystectomy for bladder cancer. He contributes to national cancer care standards as a member of the National Comprehensive Cancer Network’s panels focusing on both bladder and penile cancers and he has co-led the Pasadena Consensus Panel – an international committee that shapes global best practices in robotic surgery for bladder removal and urinary reconstruction. In the research lab, Dr. Chan concentrates on improving surgical outcomes and reducing complications through enhanced techniques and perioperative care strategies, including his pioneering use of intraoperative fluorescence imaging to assess ureteral blood flow during urinary diversion. His work also includes building a robust data registry at City of Hope focused on refining surgical approaches to male urinary incontinence following prostate and bladder cancer treatments. Additionally, he explores innovative diagnostic tools to predict treatment responses in bladder cancer patients receiving chemotherapy or immunotherapy. Dr. Chan earned his medical degree from the University of Southern California School of Medicine in Los Angeles and completed his urology residency under the guidance of renowned surgeon Donald Skinner, M.D. His contributions to the field have been recognized with multiple accolades, including the Outstanding Laparoendoscopic Resident Award from the Society of Laparoendoscopic Surgeons, the Pfizer Scholar in Urology Award and several Faculty Educator of the Year awards from City of Hope’s Urologic Oncology and Robotic Surgery Fellowship Program.